Study summary

A GLP-1 pill without food rules lowered blood sugar more than oral semaglutide

ACHIEVE-3 trial (orforglipron vs oral semaglutide) · 1,698 people, phase 3 · Published February 2026, The Lancet

1.91percentage-point drop in HbA1c with orforglipron 36 mg, vs 1.47 with semaglutide 14 mg

What was tested

Orforglipron, a once-daily small-molecule GLP-1 pill that can be taken without food or water restrictions, against oral semaglutide in type 2 diabetes not controlled on metformin.

What they found

What it means

A GLP-1 pill that is easier to take could widen access to this drug class.

Lancet, via PubMed ↗ Trial record NCT06045221 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.